Particle.news

Proposed Class Action Says Oura Overstated Sleep‑Tracking Accuracy

The lawsuit argues Oura marketed clinical‑style sleep staging it cannot directly measure and asks a court to stop the ads and return money to buyers.

Overview

  • The proposed class action was filed Aug. 20 in U.S. District Court in San Francisco and was brought by Clarkson Law Firm on behalf of plaintiff Madison Surber.
  • The complaint contends Oura rings use finger sensors for heart rate, blood‑oxygen, skin temperature, and motion and then run those signals through algorithms to estimate sleep stages rather than measuring brain waves, eye movement, or muscle tone.
  • Plaintiffs cite Oura marketing that claimed 79% agreement with polysomnography and later advertised “95% sleep‑staging accuracy compared with clinical sleep labs,” and they say those claims misled buyers.
  • The suit seeks an injunction to stop the alleged misrepresentations and restitution for purchasers; it notes Surber paid about $513.68 and says more than 100 class members seek over $5 million in damages.
  • If the case proceeds it could press legal limits on how wearable makers describe algorithmic health estimates and affect millions of users who rely on these devices for sleep guidance.